T1	Participants 38 109	patients with symptomatic paroxysmal atrial fibrillation and/or flutter
T2	Participants 316 473	patients with paroxysmal atrial fibrillation or flutter (PAF/PAFL) experiencing 2 or more episodes of symptomatic PAF/PAFL during a 28-day observation period
T3	Participants 569 581	143 patients
T5	Participants 1604 1626	patients with PAF/PAFL
